Biohaven
BHVN
242 hedge funds and large institutions have $4.07B invested in Biohaven in 2024 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 73 increasing their positions, 71 reducing their positions, and 30 closing their positions.
250% more call options, than puts
Call options by funds: $67.8M | Put options by funds: $19.4M
83% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 30
32% more capital invested
Capital invested by funds: $3.07B → $4.07B (+$998M)
11% more funds holding
Funds holding: 218 → 242 (+24)
1.67% more ownership
Funds ownership: 89.5% → 91.16% (+1.7%)
3% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 71
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$230M |
| 2 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$73.1M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$61.1M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$31.8M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$26.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$77.9M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$53.1M |
| 3 |
State Street
Boston,
Massachusetts
|
-$48.6M |
| 4 |
AC
Armistice Capital
New York
|
-$34.7M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$28.2M |
BHVN Hedge Fund Activity: Q1 2024 in Review
242 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q1 2024, worth a combined $4.07B — up 32% from $3.07B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new BHVN positions and 30 closed out — a net gain of 25 holders — while 73 added to existing stakes and 71 trimmed.
The largest buyer was Vanguard Group, adding an estimated $230M. The largest seller was Point72 Asset Management, cutting an estimated $77.9M.
- 242 institutional investors held Biohaven (BHVN) as of Q1 2024, up from 218 in Q4 2023.
- Funds reported $4.07B of Biohaven stock for Q1 2024, up 32% quarter-over-quarter.
- 55 funds opened new Biohaven positions in Q1 2024 and 30 closed out, a net change of +25 holders.
- The largest Biohaven buyer in Q1 2024 was Vanguard Group, an estimated $230M added.
- The largest Biohaven seller in Q1 2024 was Point72 Asset Management, an estimated $77.9M sold.
Based on aggregated 13F filings for Q1 2024.